Rabies vaccine for prevention before exposure
Treatments studied
Part of Infections clinical trials.
This study tests a new rabies vaccine given before any exposure to the virus, to help prevent infection. It aims to see if the vaccine is safe and creates a strong immune response in healthy people.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 1 year old.
- You should be in good health overall, without serious or worsening medical conditions in the past 3 months.
- You have not had a rabies vaccine before (either as prevention or after a bite).
- You have not been bitten by or had close contact with a possibly rabid animal in the last 12 months.
- You do not have severe allergies to vaccines or their ingredients.
- If you are a woman who could become pregnant, you must not be pregnant or breastfeeding and must use effective birth control during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests different doses of a rabies vaccine to see how well they protect against rabies and how safe they are. It's for healthy adults who may need rabies protection, for example after an animal bite or as routine prevention.
This trial tests a new freeze-dried rabies vaccine grown in human cells. It aims to confirm the vaccine is safe and works well for people aged 10 to 60 who have not been vaccinated against rabies before and have not been recently bitten by a rabid animal. By joining, you help ensure that a reliable vaccine is available to protect against this serious disease.
This trial tests a new rabies vaccine to see if it's safe and effective. It's for people who haven't been vaccinated against rabies or been bitten by a rabies-risk animal recently.
This study tests whether a new experimental rabies vaccine, when given with the standard rabies vaccine, is safe and helps the body build a strong immune response. It aims to find a better way to protect against rabies.
This study compares two ways of giving the rabies vaccine—one injected just under the skin and one injected into the muscle—to see which is safer and more effective. It may help make rabies prevention easier and less painful.
This trial provides access to an experimental medicine (SYN023) for people with rabies who have no other options. It aims to treat the infection, but since there is no standard cure, this is a special program for urgent cases.
Hear when a new Rabies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.